J. Martin Carroll - Insider Trading & Ownership

Entity
Individual
Location
C/O Catalent, Inc., 14 Schoolhouse Road, Somerset, NJ
Summary
The estimated net worth of J. Martin Carroll is at least $2.36M dollars as of November 1, 2024. J. Martin Carroll is the Director of Catalent, Inc. and owns shares of Catalent, Inc. (CTLT) stock worth about $1.96M. J. Martin Carroll is the Director of TherapeuticsMD, Inc. and owns shares of TherapeuticsMD, Inc. (TXMD) stock worth about $239K. J. Martin Carroll is the Director of Esperion Therapeutics, Inc. and owns shares of Esperion Therapeutics, Inc. (ESPR) stock worth about $161K.
All Insider Reports
All Insider Reports

Ownership of J. Martin Carroll

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CTLT Catalent, Inc. Director $1.96M Oct 30, 2024
TXMD TherapeuticsMD, Inc. Director $239K Aug 10, 2021
ESPR Esperion Therapeutics, Inc. Director $161K May 23, 2024
MNKPF Mallinckrodt plc Director Jun 16, 2022

Insider Transactions Reported by J. Martin Carroll:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.